Cargando…

A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral

Defective interfering (DI) viruses arise during the replication of influenza A virus and contain a non-infective version of the genome that is able to interfere with the production of infectious virus. In this study we hypothesise that a cloned DI influenza A virus RNA may prevent infection of human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Claire M., Scott, Paul D., O’Callaghan, Christopher, Easton, Andrew J., Dimmock, Nigel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997599/ https://www.ncbi.nlm.nih.gov/pubmed/27556481 http://dx.doi.org/10.3390/v8080237

Ejemplares similares

Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases
por: Dimmock, Nigel J., et al.
Publicado: (2015)

Defective interfering virus protects elderly mice from influenza
por: Scott, Paul D, et al.
Publicado: (2011)

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA
por: Meng, Bo, et al.
Publicado: (2017)

Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo
por: Scott, Paul D., et al.
Publicado: (2011)

Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established
por: Dimmock, Nigel J., et al.
Publicado: (2012)

Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA
por: Gould, Philip S., et al.
Publicado: (2017)

Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro
por: Pelz, Lars, et al.
Publicado: (2023)

Cell culture-based production of defective interfering particles for influenza antiviral therapy
por: Wasik, Milena A., et al.
Publicado: (2017)

A system for production of defective interfering particles in the absence of infectious influenza A virus
por: Bdeir, Najat, et al.
Publicado: (2019)

Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice
por: Dogra, Tanya, et al.
Publicado: (2023)

Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity
por: Bdeir, Najat, et al.
Publicado: (2021)

Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles
por: Fonville, Judith M., et al.
Publicado: (2015)

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity
por: Rand, Ulfert, et al.
Publicado: (2021)

Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture
por: Rüdiger, Daniel, et al.
Publicado: (2021)

Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review
por: Wu, Min, et al.
Publicado: (2022)

Influenza virus DI particles: Defective interfering or delightfully interesting?
por: Alnaji, Fadi G., et al.
Publicado: (2020)

Antiviral effect of eosinophils in respiratory tract infection with influenza virus in mice
por: Bal, Suzanne M, et al.
Publicado: (2013)

Replication of H9 influenza viruses in the human ex vivo respiratory tract, and the influence of neuraminidase on virus release
por: Chan, Renee W. Y., et al.
Publicado: (2017)

(In)validating experimentally derived knowledge about influenza A defective interfering particles
por: Liao, Laura E., et al.
Publicado: (2016)

OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
por: Hein, Marc D., et al.
Publicado: (2020)

Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy
por: Pelz, Lars, et al.
Publicado: (2021)

The receptor preference of influenza viruses
por: Meng, Bo, et al.
Publicado: (2010)

Non-Typeable Haemophilus influenzae Invasion and Persistence in the Human Respiratory Tract
por: Clementi, Cara F., et al.
Publicado: (2011)

The Battle Between Influenza and the Innate Immune Response in the Human Respiratory Tract
por: Nicholls, John M
Publicado: (2013)

The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms
por: Yang, Yicheng, et al.
Publicado: (2019)

Glycomic Analysis of Human Respiratory Tract Tissues and Correlation with Influenza Virus Infection
por: Walther, Trevenan, et al.
Publicado: (2013)

Antiviral responses against chicken respiratory infections: Focus on avian influenza virus and infectious bronchitis virus
por: Barjesteh, Neda, et al.
Publicado: (2020)

Effects of Defective Interfering Viruses on Virus Replication and Pathogenesis In Vitro and In Vivo
por: Roux, Laurent, et al.
Publicado: (1991)

Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus
por: Dimmock, Nigel J., et al.
Publicado: (2023)

Heterogeneity of Antiviral Responses in the Upper Respiratory Tract Mediates Differential Non-lytic Clearance of Influenza Viruses
por: Dumm, Rebekah E., et al.
Publicado: (2020)

Advances in antivirals for non‐influenza respiratory virus infections
por: Hayden, Frederick G.
Publicado: (2013)

Antiviral Drugs for Influenza and Other Respiratory Virus Infections
por: Aoki, Fred Y.
Publicado: (2015)

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir
por: Dimmock, Nigel J., et al.
Publicado: (2012)

Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles
por: Frensing, Timo, et al.
Publicado: (2013)

Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza
por: Zhao, Hanjun, et al.
Publicado: (2018)

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
por: Hein, Marc D., et al.
Publicado: (2021)

ADSORPTION OF INFLUENZA VIRUS ON CELLS OF THE RESPIRATORY TRACT
por: Hirst, George K.
Publicado: (1943)

THE INFLUENZA BACILLUS IN INFLAMMATIONS OF THE RESPIRATORY TRACT IN INFANTS
por: Wollstein, Martha
Publicado: (1906)

Detection of human adenoviruses in influenza-negative patients with respiratory tract infections in Nanning, China
por: Qin, Jianqiu, et al.
Publicado: (2023)

Exogenous IFN-alpha Administration Reduces Influenza A Virus Replication in the Lower Respiratory Tract of Rhesus Macaques
por: Matzinger, Shannon R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lf7vr7io2dco0l0hh7llf3n34k